Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07445087) titled 'A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea' on Feb. 25.

Study Type: Observational

Primary Sponsor: Takeda

Condition: Hereditary Angioedema (HAE)

Intervention: Other: No intervention

Recruitment Status: Not recruiting

Date of First Enrollment: May 1, 2026

Target Sample Size: 35

To know more, visit https://clinicaltrials.gov/study/NCT07445087

Published by HT Digital Content Services with permission from Health Daily Digest....